Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

121.02 -2.71 (-2.19%)
Official Closing Price Updated: 7:00 PM EDT, Jul 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,754,114
Open 122.85
Bid (Size) 120.49 (2)
Ask (Size) 126.89 (1)
Prev. Close 123.73
Today's Range 119.98 - 122.86
52wk Range 96.06 - 124.83
Shares Outstanding N/A
Dividend Yield 3.30%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Novartis Fails To Block Heart Failure Drug’s Generic From Launching Through 2026: Report
Via Stocktwits
Pfizer, Astellas Report Xtandi Survival Win In Prostate Cancer Study
Xtandi plus leuprolide improved overall survival in prostate cancer patients in the Phase 3 EMBARK trial, with no new safety concerns reported. 
Via Benzinga

Performance

YTD
+24.6%
+24.6%
1 Month
+2.5%
+2.5%
3 Month
+12.6%
+12.6%
6 Month
+22.1%
+22.1%
1 Year
+9.5%
+9.5%

More News

Read More
How Do Investors Really Feel About Novartis?
Via Benzinga
Novartis Gets Swiss Approval For First Malaria Drug For Babies
Via Benzinga
Novartis Gets Swiss Authority Nod For First Malaria Drug In Newborns, Young Infants
Via Stocktwits
Topics Death Government
$1,000 in VEA Could Turn Into $57,000
Via The Motley Fool
Topics ETFs Economy
Alphabet-Backed Drug Discovery Firm Nears Human Trials Of AI-Developed Remedies, Says President: 'The Next Big Milestone Is...'
Via Benzinga
Topics Artificial Intelligence
Better Dividend ETF to Buy for Passive Income: SCHD or GCOW
Via The Motley Fool
Topics ETFs Stocks
Novartis’ Blockbuster Drug Fails Late-Stage Trial In Disease Causing Blood Vessel Inflammation, But Retail Turns Bullish
Via Stocktwits
Novartis' Cosentyx Fails Late-Stage Giant Cell Arteritis Trial
Via Benzinga
Is Pfizer Stock a Yield Trap?
Via The Motley Fool
Topics Intellectual Property
FDA Flags Weight Loss Risk In ADHD Meds For Kids — J&J, Novartis Escape New Warning
Via Stocktwits
FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers
Via Benzinga
Could This Be the Best High-Dividend ETF to Buy Right Now?
Via The Motley Fool
Topics ETFs Economy
Incyte CEO Shake-Up Sparks M&A Buzz As RBC Analyst Highlights Meury’s Track Record: Retail Is All In
Via Stocktwits
Topics Intellectual Property
5 Biotech Stocks with Highly Anticipated Pending Results
Via Stocktwits
Topics Intellectual Property
Why New Incyte CEO Bill Meury Is Stoking Investors' M&A Hopes
Via Investor's Business Daily
Biogen-Ionis Partnered Drug Shows Benefit In Children With Spinal Muscular Atrophy Previously Treated With Novartis' Zolgensma
Via Benzinga
Can Biogen Outdo Its Own Spinal Muscular Atrophy Drug?
Via Investor's Business Daily
Shuttle Pharma Ramps Up Fight Against Glioblastoma With New Leadership, Promising Clinical Trial, and Bold Innovations
Via Stocktwits
Topics Cannabis
Analyst Flags Septerna As Undervalued Biotech Play With Significant Upside
Via Benzinga
NOVARTIS AG-SPONSORED ADR (NYSE:NVS) – A Solid Value Pick in Pharmaceuticals
Via Chartmill
Novo Nordisk Moves Amycretin Into Phase 3 Trials For Weight Management, Becomes Europe's Largest Company
Via Benzinga
Novartis' Fabhalta Delivers Hemoglobin Gains, Reduces Fatigue In Patients With Rare Blood Disorder
Via Benzinga
PU Prime Broadens Portfolio with New Global Indices
Via GlobePRwire
Topics Derivatives Economy

Frequently Asked Questions

Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 121.02
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 07/11/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.